MAC vs VRTX · rev $918.2M vs P/E 30, rev $12.00B
Macerich Company (MAC) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
Macerich Company (MAC) is a reit - retail company listed on US.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported MAC revenue for 2024-12-31 was $918.2M. Net income was -$197.7M. Revenue was up 3.9% from 2023-12-31 to 2024-12-31. MAC currently screens at market cap $4.41B.
Latest reported VRTX revenue for 2025-12-31 was $12.00B. Net income was $3.95B. Revenue was up 8.9% from 2024-12-31 to 2025-12-31. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
MAC currently screens at market cap $4.41B. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the MAC and VRTX stock pages for the full models.
Not investment advice.